Further inquiry note: Agennix AG Investor Relations & Corporate Communications Phone: +49 (0)89 8565 2693 ir@agennix.com In the U.S.: Laurie Doyle Director, Investor Relations & Corporate Communications Phone: +1 609 524 5884 laurie.doyle@agennix.com Branche: Pharmaceuticals ISIN: DE000A1A6XX4 WKN: A1A6XX Index: ...
Further inquiry note: Investor Relations & Corporate Communications Tel.: +49 (0) 89 8565 2693 E-Mail: ir@agennix.com In the U.S.: Laurie Doyle Director, Investor Relations & Corporate Communications Phone: +1 609 524 5884 laurie.doyle@agennix.com Branche: Pharmaceuticals ISIN: DE000A1A6XX4 WKN: A1A6XX Index: ...
Further inquiry note: For further information, please contact: ElringKlinger AG Corporate Communications/Investor Relations Stephan Haas Max-Eyth-Straße 2 72581 Dettingen/Erms Phone: +49 (0)7123 724-137 E-mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, Classic All Share, Prime All Share Börsen: Frankfurt ...
Further inquiry note: Agennix AG Investor Relations & Corporate Communications Phone: +49 (0)89 8565 2693 ir@agennix.com In the U.S.: Laurie Doyle Director, Investor Relations & Corporate Communications Phone: +1 609 524 5884 laurie.doyle@agennix.com Additional media contacts for Europe: MC Services AG Raimund ...
Further inquiry note: PNE WIND AG Presse- und Öffentlichkeitsarbeit Rainer Heinsohn Tel: +49(0) 47 21 - 7 18 - 4 53 Fax: +49(0) 47 21 - 7 18 - 3 73 E-mail: info@pnewind.com Investor Relations cometis AG Ulrich Wiehle / Alexandra Edinger Tel: +49(0)611 - 205855-16 Fax: +49(0)611 - 205855-66 E-mail: ...
Further inquiry note: For further information, please contact: ElringKlinger AG Investor Relations/PR Max-Eyth-Straße 2, 72581 Dettingen/Erms Phone: +49 (0)7123-724-640 / 137 Fax: +49 (0)7123-724-641 E-mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, Classic All Share, Prime All Share Börsen: Frankfurt / ...
Further inquiry note: For further information, please contact: ElringKlinger AG Investor Relations/PR Max-Eyth-Straße 2, 72581 Dettingen/Erms Phone: +49 (0)7123-724-640 / 137 Fax: +49 (0)7123-724-641 E-mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, Classic All Share, Prime All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade ...
Further inquiry note: Investor Relations & Corporate Communications Tel.: +49 (0) 89 8565 2693 E-Mail: ir@agennix.com Branche: Pharmaceuticals ISIN: DE000A1A6XX4 WKN: A1A6XX Index: CDAX, Prime All Share, Technology All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade Hamburg / free ...
Further inquiry note: For further information, please contact: Agennix AG Investor Relations & Corporate Communications Phone: +49 (0)89 8565 2693 ir@agennix.com In the U.S.: Laurie Doyle Director, Investor Relations & Corporate Communications Phone: +1 609 524 5884 laurie.doyle@agennix.com Additional media ...
Further inquiry note: Agennix AG Investor Relations & Corporate Communications Phone: +49 (0)89 8565 2693 ir@agennix.com In the U.S.: Laurie Doyle Director, Investor Relations & Corporate Communications Phone: +1 609 524 5884 laurie.doyle@agennix.com Additional media contact for Europe: MC Services AG Raimund ...
Further inquiry note: Agennix AG Investor Relations & Corporate Communications Phone: +49 (0)89 8565 2693 ir@agennix.com In the U.S.: Laurie Doyle Director, Investor Relations & Corporate Communications Phone: +1 609 524 5884 laurie.doyle@agennix.com Additional media contact for Europe: MC Services AG Raimund ...
Further inquiry note: Agennix AG Investor Relations & Corporate Communications Phone: +49 (0)89 8565 2693 ir@agennix.com In the U.S.: Laurie Doyle Director, Investor Relations & Corporate Communications Phone: +1 609 524 5884 laurie.doyle@agennix.com Additional media contact for Europe: MC Services AG Raimund Gabriel Phone: +49 (0)89 210 228 0 raimund.gabriel@mc-services.eu Additional investor contact for Europe: Trout International LLC Lauren Williams, Vice President ...
Further inquiry note: Agennix AG Investor Relations & Corporate Communications Phone: +49 (0)89 8565 2693 ir@agennix.com In the U.S.: Laurie Doyle Director, Investor Relations & Corporate Communications Phone: +1 609 524 5884 laurie.doyle@agennix.com Additional media contact for Europe: MC Services AG Raimund Gabriel Phone: +49 (0) 89 210 228 0 raimund.gabriel@mc-services.eu Additional investor contact for Europe: Trout International LLC Lauren Williams, Vice President ...
Further inquiry note: For further information, please contact: ElringKlinger AG Corporate Communications/Investor Relations Stephan Haas Max-Eyth-Straße 2 72581 Dettingen/Erms Phone: +49 (0)7123 724-137 E-mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, Classic All Share, Prime All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free ...
Further inquiry note: For further information, please contact: Agennix AG Investor Relations & Corporate Communications Phone: +49 (0)89 8565 2693 ir@agennix.com In the U.S.: Laurie Doyle Director, Investor Relations & Corporate Communications Phone: +1 609 524 5884 laurie.doyle@agennix.com Additional media contacts for Europe: MC Services AG Phone: +49 (0) 89 210 228 0 Raimund Gabriel raimund.gabriel@mc-services.eu Hilda Juhasz hilda.juhasz@mc-services.eu Additional ...
Further inquiry note: Agennix AG Investor Relations & Corporate Communications Phone: +49 (0)89 8565 2693 ir@agennix.com In the U.S.: Laurie Doyle Director, Investor Relations & Corporate Communications Phone: +1 609 524 5884 laurie.doyle@agennix.com Additional media contacts for Europe: MC Services AG Phone: +49 (0) 89 210 228 0 Raimund Gabriel raimund.gabriel@mc-services.eu Hilda Juhasz hilda.juhasz@mc-services.eu Additional investor contact for Europe: Trout ...
Further inquiry note: For further information, please contact: ElringKlinger AG Corporate Communications / Investor Relations Stephan Haas Max-Eyth-Straße 2 72581 Dettingen Fon: +49 (0)7123-724-631; +49 (0)170-9246264; Fax: +49 (0)7123-724-641 E-mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, Classic All ...
Further inquiry note: Stephan Haas Telefon: +49(0)7123 724 631 E-Mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, Classic All Share, Prime All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade Düsseldorf / free trade ...
Further inquiry note: Stephan Haas Telefon: +49(0)7123 724 137 E-Mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, Classic All Share, Prime All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade Düsseldorf / free trade ...
Ludwigshafen (ots) - Just like animals and human beings, plants can get sick. In many cases, the cause is a fungus. Not a mushroom like you see poking up out of the ground in the woods, but a network of branching, filamentary cells that botanists call 'hyphae'. In entertaining episodes our Chemical Reporter answers questions of our Podcast listeners ...
Further inquiry note: LPKF Laser & Electronics AG Bettina Schäfer, Investor Relations Tel: (05131) 7095-382 Branche: Semiconductors & active components ISIN: DE0006450000 WKN: 645000 Index: CDAX, Prime All Share, Technology All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade ...
init innovation in traffic systems AG
- Innovation Award for new online diversion module in operations control system - Prompt reaction to current traffic disruptions, real-time information for passengers - On-road test at Bavarian transportation provider DB Stadtverkehr Further inquiry note: Alexandra Weiß Investor Relations Telefon: +49(0)721 ...
Ingelheim, Germany (ots/PRNewswire) - Boehringer Ingelheim announced today the initiation of a new phase III clinical trial to evaluate one of its two late-stage oncology pipeline compounds for the treatment of patients with advanced ovarian cancer. The clinical study, called LUME-Ovar-1 trial, investigates the compound BIBF 1120, a novel oral anti-angiogenic agent[1], ...
Further inquiry note: For further information, please contact: ElringKlinger AG Investor Relations / Corporate Communications Stephan Haas Max-Eyth-Straße 2 72581 Dettingen Phone: +49 0 7123-724-137 E-mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, Classic All Share, Prime All Share Börsen: Frankfurt / ...
- SCHOTT Solar acquires WACKER's shares in joint venture - WACKER is expecting from the transaction a non-recurring negative effect on pre-tax profit of about 50 million, financial debt to increase by some 65 million - CEO Staudigl: Focus on polysilicon production provides an excellent base for long-term competitiveness and profitability Further inquiry note: Christof Bachmair Media Relations & Information Tel.: ...
Further inquiry note: Investor Relations Tel.: +49 (0)89 6279 1633 E-Mail: investor.relations@wacker.com Branche: Chemicals ISIN: DE000WCH8881 WKN: WCH888 Index: Midcap Market Index, MDAX, CDAX, Classic All Share, HDAX, Prime All Share Börsen: Frankfurt / regulated dealing/prime standard ...
Ludwigshafen (ots) - In this podcast you will learn how chemical innovations from BASF help to make solar energy more economical on its way being a sustainable contribution to the worldwide energy supply. As a part of the future energy mix with other energy sources solar energy can make a sustainable contribution towards a low carbon society. In ...
Further inquiry note: For further information, please contact: ElringKlinger AG Corporate Communications / Investor Relations Stephan Haas Max-Eyth-Straße 2 72581 Dettingen Phone: +49 0 7123-724-137 E-mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, ...
Ingelheim, Germany (ots/PRNewswire) - - Data From Phase II Studies Investigating BIBW 2992 (Tovok(TM)) and BIBF 1120 (Vargatef(TM)) in NSCLC Patients Presented at 13th World Conference on Lung Cancer (WCLC) INGELHEIM, Germany, August 3 /PRNewswire/ -- Boehringer Ingelheim announced today at the International ...
Cape Town, South Africa (ots/PRNewswire) - - For Medical Media Outside the US Only Results from the ARTEN* trial presented at the 5th International AIDS Society (IAS) conference in Cape Town, South Africa demonstrated non-inferiority regarding efficacy between Viramune(R) (nevirapine) and ritonavir boosted ...
